
Richter BioLogics
Hamburg, Germany richterbiologics.eu From their website, Nov 2026
- GMP
Work here? Claim this listing
About
Richter BioLogics is a Germany-based CDMO that develops and manufactures biopharmaceuticals derived from bacteria and yeasts. It serves pharmaceutical and biotechnology customers worldwide from locations in Hamburg and Bovenau, with production facilities in Germany and locations also noted in Hungary.
Services
Strain development
Develops strains based on E. coli host systems for peptides, proteins, plasmid DNA products, and vaccines.
Cell line development
Fermentation development
Provides batch and fed-batch fermentation development, including feasibility studies, scale-up, adaptation, optimization, and reproducibility studies.
Cell line development
Downstream process development
Develops purification and downstream processes including capture, intermediate purification, polishing, and process optimization.
Cell line development
Process characterization
Establishes scale-down models and characterizes process parameters for fermentation, chromatography, and TFF.
Cell line development
Analytical development
Develops product- and process-specific analytical methods, including HCP ELISAs, bioassays, and stability-indicating methods.
GMP quality control
Performs GMP-compliant QC testing, method transfer and validation, in-process and release testing, comparability testing, microbiological testing, and stability testing.
Drug substance manufacturing
Manufactures biological drug substances in cGMP facilities for phase I to III and commercial supply.
CDMO: development & manufacturing
Capabilities
- Assays and studies
- Process development
- E. coli expression
- Antibodies
- Peptides
- Analytical development
- Bioreactors
16 more
- HPLC
- Method transfer
- Method validation
- Analytical procedure validation
- Lifecycle management
- In-process testing
- Release testing
- Comparability testing
- Microbiological testing
- ICH conform stability testing
- Raw material testing
- Cleaning verification
- Cell bank characterization
- Bioassay
- Biosimilarity testing
- Stability-indicating methods
- Scale and capacity
- 300L production capacity
- 1500L production capacity
- Bioreactor capacities of up to 1,500 litres
- Small scale 0.3L
- Small scale 1.0L
- Intermediate scale-up to 10L
- Two multiproduct GMP facilities
- Complete lab space of 1325 sqm
Instruments and platforms
- FPLC
- HPLC
- UV/VIS spectrometry
- AGE
- PAGE/WB
- DLS
3 more
- Nano-DSF
- Crossflow filtration
- Tangential flow filtration (TFF)
Modalities and species
- Modalities
- Antibody
- Peptide
- Recombinant protein
- Vaccine
- Plasmid DNA
- Species and models
- E. coli
- Pichia
- Yeasts
- Bacteria
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Scope: manufacturing and quality system
Details
- Type
- CRDMO
- Founded
- 1987
- Office
- offering 300L and 1500L production capacities. As a GMP biologics facilit
- Sites
- Bovenau, Germany
- Serves
- Worldwide, Europe, USA, Brazil, South Korea
Public records
- FDA drug establishment registration
- 3006553942 · ANALYSIS source